Verastem Statistics
Total Valuation
Verastem has a market cap or net worth of $797.67 million. The enterprise value is $753.43 million.
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Verastem has 126.01 million shares outstanding. The number of shares has increased by 58.04% in one year.
| Current Share Class | 126.01M |
| Shares Outstanding | 126.01M |
| Shares Change (YoY) | +58.04% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 68.77% |
| Float | 118.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.95 |
| Forward PS | 6.48 |
| PB Ratio | 59.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 12.73.
| Current Ratio | 1.93 |
| Quick Ratio | 1.77 |
| Debt / Equity | 12.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -141.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -59.75% |
| Return on Invested Capital (ROIC) | -114.24% |
| Return on Capital Employed (ROCE) | -153.83% |
| Weighted Average Cost of Capital (WACC) | 5.95% |
| Revenue Per Employee | $983,294 |
| Profits Per Employee | -$1.75M |
| Employee Count | 102 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 6.33 |
Taxes
In the past 12 months, Verastem has paid $816,000 in taxes.
| Income Tax | 816,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.72% in the last 52 weeks. The beta is 0.46, so Verastem's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -31.72% |
| 50-Day Moving Average | 8.41 |
| 200-Day Moving Average | 6.31 |
| Relative Strength Index (RSI) | 27.65 |
| Average Volume (20 Days) | 3,088,217 |
Short Selling Information
The latest short interest is 19.67 million, so 15.61% of the outstanding shares have been sold short.
| Short Interest | 19.67M |
| Short Previous Month | 17.20M |
| Short % of Shares Out | 15.61% |
| Short % of Float | 16.58% |
| Short Ratio (days to cover) | 3.70 |
Income Statement
In the last 12 months, Verastem had revenue of $100.30 million and -$178.90 million in losses. Loss per share was -$1.97.
| Revenue | 100.30M |
| Gross Profit | 87.48M |
| Operating Income | -194.31M |
| Pretax Income | -178.09M |
| Net Income | -178.90M |
| EBITDA | -193.17M |
| EBIT | -194.31M |
| Loss Per Share | -$1.97 |
Full Income Statement Balance Sheet
The company has $172.80 million in cash and $128.56 million in debt, with a net cash position of $44.24 million or $0.35 per share.
| Cash & Cash Equivalents | 172.80M |
| Total Debt | 128.56M |
| Net Cash | 44.24M |
| Net Cash Per Share | $0.35 |
| Equity (Book Value) | 10.10M |
| Book Value Per Share | 0.11 |
| Working Capital | 96.05M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -159.57M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.14M |
| Net Borrowing | 46.06M |
| Free Cash Flow | -159.57M |
| FCF Per Share | -$1.27 |
Full Cash Flow Statement Margins
Gross margin is 87.23%, with operating and profit margins of -193.73% and -178.38%.
| Gross Margin | 87.23% |
| Operating Margin | -193.73% |
| Pretax Margin | -177.56% |
| Profit Margin | -178.38% |
| EBITDA Margin | -192.60% |
| EBIT Margin | -193.73% |
| FCF Margin | n/a |
Dividends & Yields
Verastem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -58.04% |
| Shareholder Yield | -58.04% |
| Earnings Yield | -31.06% |
| FCF Yield | -20.00% |
Analyst Forecast
The average price target for Verastem is $17.22, which is 172.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.22 |
| Price Target Difference | 172.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 89.42% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 1, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
Verastem has an Altman Z-Score of -8.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.38 |
| Piotroski F-Score | 3 |